Icon Group invests in lymphoedema screening across Australia and New Zealand

“Through the implementation of lymphoedema screening Icon is helping patients take control from the very start of their cancer journey. At a time when there are so many uncertainties for a patient, this service arms them with important knowledge to manage their wellbeing throughout surgery, treatment and beyond,” said Mark Middleton, Icon Group CEO.

SOZO, as a digitally connected health platform, gives ImpediMed the ability to see patient testing in real-time, anywhere in the world. This real-time insight allows ImpediMed to tailor its approach by better managing and reallocating resources when opportunities arise, continuing to evolve services, foster long-term business relationships and help deliver the best possible care.

“We are proud to work with providers like Icon who strive for the highest levels of care for cancer patients and survivors. This agreement opens the door to thousands of patients to participate in a state-of-the-art lymphoedema prevention program aimed at stopping chronic lymphoedema before it starts,” said Richard Carreon, Managing Director and CEO of ImpediMed.